FINWIRES · TerminalLIVE
FINWIRES

Leerink Partners Downgrades Fulcrum Therapeutics to Market Perform From Outperform, Adjusts PT to $4 From $24

By

Fulcrum Therapeutics (FULC) has an average rating of hold and mean price target of $9.22, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Research

Jefferies Downgrades StandardAero to Hold From Buy, Adjusts Price Target to $30 From $34

StandardAero (SARO) has an average rating of buy and mean price target of $35.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SARO
Research

Evercore ISI Upgrades Guardant Health to Outperform From In Line, Adjusts PT to $160 From $95

Guardant Health (GH) has an average rating of overweight and mean price target of $134.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$GH
Research

Avendus Spark Upgrades Siemens to Add from Reduce; Price Target is INR4,214

Siemens (NSE:SIEMENS, BOM:500550) has an average rating of hold and mean price target of 3,659.81 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BOM:500550$NSE:SIEMENS